Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers

Lung cancer is the leading cause of cancer-related deaths worldwide. The standard of care for advanced non-small-cell lung cancer (NSCLC) without driver-gene mutations is a combination of an anti-PD-1/PD-L1 antibody and chemotherapy, or an anti-PD-1/PD-L1 antibody and an anti-CTLA-4 antibody with or...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Biomedicines
المؤلفون الرئيسيون:	Satoshi Muto, Akio Enta, Yoshiyuki Maruya, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Masayuki Watanabe, Takuya Inoue, Takumi Yamaura, Mitsuro Fukuhara, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio, Kazuyuki Hamada, Hiroyuki Suzuki
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2023-01-01
الموضوعات:	immune checkpoint inhibitors tumor escape immunomodulation tumor microenvironment beta catenin Wnt signaling pathway
الوصول للمادة أونلاين:	https://www.mdpi.com/2227-9059/11/1/190